BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29037445)

  • 21. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy.
    Maeder MT; Rickli H; Pfisterer ME; Muzzarelli S; Ammann P; Fehr T; Hack D; Weilenmann D; Dieterle T; Kiencke S; Estlinbaum W; Brunner-La Rocca HP;
    Am Heart J; 2012 Mar; 163(3):407-14, 414.e1. PubMed ID: 22424011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: Analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database.
    Karamlou T; Welke KF; McMullan DM; Cohen GA; Gelow J; Tibayan FA; Mudd JM; Slater MS; Song HK
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):456-461.e1. PubMed ID: 24183335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
    Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
    Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of renal function on prognosis in chronic heart failure.
    Löffler AI; Cappola TP; Fang J; Hetzel SJ; Kadlec A; Astor B; Sweitzer NK
    Am J Cardiol; 2015 Jan; 115(1):62-8. PubMed ID: 25465925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device.
    Pinsino A; Mondellini GM; Royzman EA; Hoffman KL; D'Angelo D; Mabasa M; Gaudig A; Zuver AM; Masoumi A; Garan AR; Mohan S; Husain SA; Toma K; Faillace RT; Giles JT; Takeda K; Takayama H; Naka Y; Topkara VK; Demmer RT; Radhakrishnan J; Colombo PC; Yuzefpolskaya M
    Circ Heart Fail; 2020 Jan; 13(1):e006326. PubMed ID: 31959016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in renal function after left ventricular assist device placement in pediatric patients: A Pedimacs analysis.
    Friedland-Little JM; Hong BJ; Gossett JG; Deshpande SR; Law S; Hollifield KA; Cantor RS; Koehl D; Kindel SJ; Turrentine MW; Davies RR
    J Heart Lung Transplant; 2018 Oct; 37(10):1218-1225. PubMed ID: 30293616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in health-related quality of life from before to after destination therapy mechanical circulatory support is similar for older and younger patients: analyses from INTERMACS.
    Grady KL; Naftel DC; Myers S; Dew MA; Weidner G; Spertus JA; Idrissi K; Lee HB; McGee EC; Kirklin JK
    J Heart Lung Transplant; 2015 Feb; 34(2):213-21. PubMed ID: 25578625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Durability of central aortic valve closure in patients with continuous flow left ventricular assist devices.
    McKellar SH; Deo S; Daly RC; Durham LA; Joyce LD; Stulak JM; Park SJ
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):344-8. PubMed ID: 23246052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of Moderate-to-Severe Acute Kidney Injury following Left Ventricular Assist Device Implantation.
    Harmon DM; Tecson KM; Lima B; Collier JDG; Shaikh AF; Still S; Baxter RD; Lew N; Thakur R; Felius J; Hall SA; Gonzalez-Stawinski GV; Joseph SM
    Cardiorenal Med; 2019; 9(2):100-107. PubMed ID: 30673661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation.
    Asleh R; Schettle S; Briasoulis A; Killian JM; Stulak JM; Pereira NL; Kushwaha SS; Maltais S; Dunlay SM
    Mayo Clin Proc; 2019 Jun; 94(6):1003-1014. PubMed ID: 31171114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support.
    Jedeon Z; Cogswell R; Schultz J; Von Wald L; John R; Roukoz H
    Sci Rep; 2021 Sep; 11(1):19196. PubMed ID: 34584108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Baseline Mitral Regurgitation on Postoperative Outcomes After Left Ventricular Assist Device Implantation as Destination Therapy.
    Okoh A; Yanagida R; Schultheis M; Chaudari S; Fugar S; Nnaoma C; Chan O; Zucker MJ; Karanam R; Russo MJ; Camacho M
    Transplant Proc; 2019 Apr; 51(3):859-864. PubMed ID: 30979476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal Function Changes Following Left Ventricular Assist Device Implantation.
    Daimee UA; Wang M; Papernov A; Sherazi S; McNitt S; Vidula H; Chen L; Alexis JD; Kutyifa V
    Am J Cardiol; 2017 Dec; 120(12):2213-2220. PubMed ID: 29050685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Renal Outcomes in Patients With Left Ventricular Assist Device and Heart Transplantation.
    Arshad A; Kew EP; Lim S
    Transplant Proc; 2019 Dec; 51(10):3395-3398. PubMed ID: 31810507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Implications of Renal Dysfunction in Patients With Aortic Stenosis.
    Vollema EM; Prihadi EA; Ng ACT; Gegenava T; Ajmone Marsan N; Bax JJ; Delgado V
    Am J Cardiol; 2020 Apr; 125(7):1108-1114. PubMed ID: 31982104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.